Cat.#: BBM-C-149
Description | Bovine astrocytes from Ace Therapeutics are isolated from the bovine brain and are cryopreserved at passage one. Bovine astrocytes are characterized by immunofluorescence with antibody specific to GFAP. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen. |
Species | Bovine |
Source | Brain |
Recommended Medium | It is recommended to use Bovine Astrocyte Medium Kit for culturing in vitro. |
Cell Type | Astrocytes |
Disease | Normal |
Quality Control | Bovine Astrocytes test negative for bacteria, yeast, fungi, and mycoplasma. |
Shipping and Storage | Ace Therapeutics ships frozen cells using dry ice. Upon receiving the frozen cells, immediately move them into liquid nitrogen (-180 °C) for storage. Note: Never can cells be kept at -20 °C, and repeated freezing and thawing of cells is not recommended. |
Applications | Bovine Astrocytes are a useful in vitro model for studying glial function and the molecular mechanisms of CNS diseases such as ischemic stroke and multiple sclerosis. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-C-131 | Cynomolgus Monkey Brain Microvascular Endothelial Cells |
Cynomolgus Monkey Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from Cynomolgus monkey brain tissue. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-135 | Mouse Brain Vascular Pericytes (MBVP) |
Mouse Brain Vascular Pericytes (MBVP) from Ace Therapeutics are isolated from adult mouse brains and cryopreserved at P2. MBVP express Neural/glial antigen 2 (NG2) and α-smooth muscle actin. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-145 | Wistar Rat Astrocytes |
Characterization: 1. Cell Activity;
– Recovery Viability ≥ 80%.
2. Cell Purity;
– GFAP-positive cells ≥ 70%.
– β-tubulin III- or doublecortin- (Dcx-) positive cells ≤ 10%.
– GalC-positive cells ≤ 10%.
|
inquiry |
BBM-C-146 | Sprague-Dawly (SD) Rat Astrocytes |
Characterization: 1. Cell Activity;
– Recovery Viability ≥ 80%.
2. Cell Purity;
– GFAP-positive cells ≥ 70%.
– β-tubulin III- or doublecortin- (Dcx-) positive cells ≤ 10%.
– GalC-positive cells ≤ 10%.
|
inquiry |
BBM-C-144 | Rat Astrocytes |
Rat Astrocytes (RA) from Ace Therapeutics are isolated from postnatal day 2 rat brains and are cryopreserved as primary cultures. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-133 | Canine Brain Microvascular Endothelial Cells |
Canine Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from the brain of a pathogen-free laboratory beagle dog. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-147 | Rat Astrocytes-midbrain |
Rat astrocytes-midbrain (RA-mb) from Ace Therapeutics are isolated from CD® IGS rat midbrain and are cryopreserved at P0. RA-mb are characterized by immunofluorescence with antibodies specific to GFAP. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-128 | BALB/c Mouse Brain Microvascular Endothelial Cells |
BALB/c Mouse Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from the brain tissue of pathogen-free laboratory mice. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-140 | Mouse Astrocytes-hippocampal from CD1 |
Mouse Astrocytes-hippocampal from CD1 from Ace Therapeutics are isolated from postnatal day 2 mouse hippocampus and are cryopreserved as primary cultures. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-138 | C57BL/6 Mouse Astrocytes |
C57BL/6 Mouse Astrocytes from Ace Therapeutics are isolated from brain tissues of pathogen-free laboratory mice. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.